Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients (X-MEN)

This study has been completed.
Sponsor:
Collaborators:
Seoul National University Bundang Hospital
Seoul St. Mary's Hospital
Korea University
Bobath Memorial Hospital
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
Hanyang University
Kwandong University Myongji Hospital
Inha University Hospital
SungAe General Hospital
Ewha Womans University
Inje University
Hanyang University Seoul Hospital
Kyunghee University Medical Center
Hallym University Medical Center
Pusan National University Hospital
Konyang University Hospital
Wonkwang University Sanbon Medical Center
Yong-in Hyoja Geriatric Hospital
Jeju National University
Dong-A University Hospital
Information provided by (Responsible Party):
SangYun Kim, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT01312363
First received: October 26, 2010
Last updated: May 2, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2011
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)